Amid concerns that reports of rare side-effects could undermine vaccine confidence, experts have emphasised that clotting risks for both sh...

The advice for healthcare professionals was provided by the European Medicines Agency (EMA) as part of an ongoing review into rare, but sev...

The European Medicines Agency (EMA) was presenting its findings after the European Commission asked it to look into concerns that prompted ...

The agency said there were "no or limited data to change current recommendations." It said it wasn't known whether the risk of a rare blood...

Earlier this month, the Amsterdam-based drug regulator for the 27-nation European Union said there was a "possible link" between the AstraZ...

AstraZeneca, which had been buffeted by similar blood-clotting concerns for weeks, agreed, while Pfizer Inc and Moderna executive declined,...

Concerning symptoms may occur a week to three weeks after the J&J vaccine.

With both the AstraZeneca and Johnson & Johnson (J&J)vaccines, the reports involve extremely rare clotting, including a type of blood clot ...

The government had been in talks with the New Jersey-based pharmaceutical giant, which had asked the Australian regulator, Therapeutic Good...

WHO said there is an acute shortage of vaccines and most countries did not have any doses to cover frontline workers such as healthcare sta...

The EMA said its vaccine side effects monitoring system, as of April 4, had received 169 reports of cases of cerebral venous sinus thrombos...

The decision was announced soon after the European Union's drug regulator said it had found a ``possible link'' between the AstraZeneca cor...

No specific risk factors, including age, have been identified for thrombosis with the AstraZeneca shot, which could stem from an immune res...

MHRA, European Medicines Agency and the World Health Organization have reiterated that benefits of the vaccine in the prevention of COVID-1...

Australia launched mass vaccinations for its 25 million people in February, with most expected to receive the University of Oxford/AstraZen...

Earlier in March, more than a dozen countries, including Germany, suspended their use of AstraZeneca over the blood clot issue.

A growing number of European countries - including Germany, France, Italy and Spain - suspended use of the AstraZeneca vaccine on Monday, t...